Jd. Bagdade et al., ACCELERATED CHOLESTERYL ESTER TRANSFER IN PATIENTS WITH ESSENTIAL-HYPERTENSION AND THE EFFECT OF RAMIPRIL TREATMENT, Atherosclerosis (Amsterdam), 140(1), 1998, pp. 167-172
Although the transfer of cholesteryl ester (CE) from high-density lipo
protein (HDL) to the apolipoprotein B-containing lipoproteins (very-lo
w-density lipoproteins + low-density lipoproteins) has been shown to b
e abnormally increased in a number of conditions associated with incre
ased cardiovascular risk, it has not been studied in patients with ess
ential hypertension (EH). To determine whether subjects with EH have i
ncreased CE transport, CE transfer (CET) was estimated isotopically an
d lipoprotein lipid and phospholipid composition determined in a group
of 14 untreated normolipidemic (triglycerides 116 +/- 46, cholesterol
185 +/- 30, HDL 38 +/- 10 mg/dl) otherwise healthy ethnically diverse
EH subjects. CET was significantly increased in EH subjects compared
to a similar group of normotensive controls (EH: k = 0.27 +/- 0.09 vs.
control k = 0.11 +/- 0.02; P < 0.01). Lipoprotein concentration and c
omposition were comparable in the two groups and closely resembled tha
t of an age- and sex-matched reference group. The abnormal increase in
CET persisted (k = 0.25 +/- 0.12) after 3 months of treatment with th
e angiotensin converting enzyme (ACE) inhibitor ramipril without a cha
nge in either plasma or lipoprotein lipids. Thus, CET is increased in
normolipidemic subjects with EH and is not affected by the ACE inhibit
or ramipril, (C) 1998 Elsevier Science Ireland Ltd. All rights reserve
d.